BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

835 related articles for article (PubMed ID: 18162772)

  • 1. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases.
    Wang W; Epstein JI
    Am J Surg Pathol; 2008 Jan; 32(1):65-71. PubMed ID: 18162772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostatic adenocarcinoma metastases mimicking small cell carcinoma on fine-needle aspiration.
    Parwani AV; Ali SZ
    Diagn Cytopathol; 2002 Aug; 27(2):75-9. PubMed ID: 12203872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum calcitonin in small cell carcinoma of the prostate.
    Sim SJ; Glassman AB; Ro JY; Lee JJ; Logothetis CJ; Liu FJ
    Ann Clin Lab Sci; 1996; 26(6):487-95. PubMed ID: 8908318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of small cell carcinoma of the prostate].
    Murao T; Tanahashi T
    Gan No Rinsho; 1988 Sep; 34(11):1624-8. PubMed ID: 2846913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Papillary adenocarcinoma of the prostate: report of 4 cases].
    Miki J; Ikemoto I; Shimomura T; Kiyota H; Oisi Y; Kondo I; Madarame J; Endo K; Takahashi H
    Hinyokika Kiyo; 2003 Jan; 49(1):21-4. PubMed ID: 12629776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study.
    Turbat-Herrera EA; Herrera GA; Gore I; Lott RL; Grizzle WE; Bonnin JM
    Arch Pathol Lab Med; 1988 Nov; 112(11):1100-5. PubMed ID: 2460064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological features correlation with serum tumour markers in prostatic carcinoma.
    Afzal S; Ahmad M; Mushtaq S; Mubarik A; Qureshi AH; Khan SA
    J Coll Physicians Surg Pak; 2003 Sep; 13(9):511-4. PubMed ID: 12971871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare prostatic carcinomas: histogenesis and morphologic pattern.
    Losi L; Brausi M; Di Gregorio C
    Pathologica; 1994 Aug; 86(4):366-70. PubMed ID: 7708435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma.
    Bassily NH; Vallorosi CJ; Akdas G; Montie JE; Rubin MA
    Am J Clin Pathol; 2000 Mar; 113(3):383-8. PubMed ID: 10705819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of prostatic small cell carcinoma].
    Hashimoto Y; Kimura G; Tsuboi N; Akimoto M
    Hinyokika Kiyo; 2000 Jun; 46(6):425-7. PubMed ID: 10934615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The morphologic spectrum of metastatic prostatic adenocarcinoma to the lung: special emphasis on histologic features overlapping with other pulmonary neoplasms.
    Copeland JN; Amin MB; Humphrey PA; Tamboli P; Ro JY; Gal AA
    Am J Clin Pathol; 2002 Apr; 117(4):552-7. PubMed ID: 11939729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary seminal vesicle carcinoma: an immunohistochemical analysis of four cases.
    Ormsby AH; Haskell R; Jones D; Goldblum JR
    Mod Pathol; 2000 Jan; 13(1):46-51. PubMed ID: 10658909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prostatic adenocarcinoma with neuroendocrine differentiation of the small cell type].
    Rimoldi DA; Antonio Costa J; Roveto S; Rivero O
    Medicina (B Aires); 2001; 61(3):322-4. PubMed ID: 11474882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical staining and serotest markers during development of a sarcomatoid and small cell prostate tumor.
    Frković-Grazio S; Kraljić I; Trnski D; Tarle M
    Anticancer Res; 1994; 14(5B):2151-6. PubMed ID: 7840515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metallothionein expression in prostatic carcinoma: correlation with Gleason grade, pathologic stage, DNA content and serum level of prostate-specific antigen.
    Moussa M; Kloth D; Peers G; Cherian MG; Frei JV; Chin JL
    Clin Invest Med; 1997 Dec; 20(6):371-80. PubMed ID: 9413634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostatic carcinoma with signet ring cells: a clinicopathologic and immunohistochemical analysis of 12 cases, with review of the literature.
    Torbenson M; Dhir R; Nangia A; Becich MJ; Kapadia SB
    Mod Pathol; 1998 Jun; 11(6):552-9. PubMed ID: 9647593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma.
    Genega EM; Hutchinson B; Reuter VE; Gaudin PB
    Mod Pathol; 2000 Nov; 13(11):1186-91. PubMed ID: 11106075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphology and therapeutic strategies for neuroendocrine tumors of the genitourinary tract.
    Helpap B
    Cancer; 2002 Oct; 95(7):1415-20. PubMed ID: 12237909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced prostate cancer with normal serum prostate-specific antigen values.
    Cohen RJ; Haffejee Z; Steele GS; Nayler SJ
    Arch Pathol Lab Med; 1994 Nov; 118(11):1123-6. PubMed ID: 7526818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesonephric remnants of the prostate: incidence and histologic spectrum.
    Bostwick DG; Qian J; Ma J; Muir TE
    Mod Pathol; 2003 Jul; 16(7):630-5. PubMed ID: 12861057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.